Telitacicept for Refractory Chronic Inflammatory Demyelinating Polyneuropathy
Telitacicept for Refractory Chronic Inflammatory Demyelinating Polyneuropathy
Active, not recruiting · NCT07597733 · Registry updated 2026-05-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Telitacicept for Refractory Chronic Inflammatory Demyelinating Polyneuropathy | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic inflammatory demyelinating polyradiculoneuropathy, demyelinating disease, immune system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathy | Active, not recruiting | Not applicable | 2026-05-19 | NCT07597733 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sichuan Academy of Medical Sciences | 16 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sichuan Provincial People's Hospital | Chengdu | China | 50 |